Literature DB >> 7072615

Morphological evidence of reduced bone resorption in osteopetrotic (op) mice.

S C Marks.   

Abstract

Osteopetrosis, a metabolic bone disease in which a generalized accumulation of bone mass reduces or obliterates marrow cavities, is inherited as an autosomal recessive in several mammalian species. A recently discovered mutation in mice, the osteopetrosic (op) mutation, exhibits an elevation in bone matrix synthesis and a resistance to the hypercalcemic effects of exogenous parathyroid extract when young mutants are compared with normal littermates. This investigation examined the number, cytology, and ultrastructure of osteoclasts and the structure of bone surfaces in op mice in a morphologic assessment of bone resorption. Compared with normal littermates, op mice have a severe deficiency of osteoclasts, which also contain unusual toluidine blue-positive and electron-dense cytoplasmic inclusions and hypertrophy of clear zones and ruffled borders. Marrow spaces in op mice contained large numbers of megakaryocytes and large lipoid masses. Bone surfaces exhibiting evidence of resorption by scanning electron microscopy in normal littermates showed no evidence of resorption in op mice. Instead, these areas were characterized by morphologic features of bone formation. These data offer morphologic evidence of a reduction of bone resorption in this mutation. They are interpreted to mean 1) that op mice have a severe reduction in numbers or proliferative capacity of osteoclast precursors, which may be related to the cellular inclusions in the osteoclast population, and 2) that hypertrophy of the ruffled borders and clear zones of op osteoclasts is a compensatory attempt to increase bone resorption.

Entities:  

Mesh:

Year:  1982        PMID: 7072615     DOI: 10.1002/aja.1001630205

Source DB:  PubMed          Journal:  Am J Anat        ISSN: 0002-9106


  15 in total

Review 1.  Novel approaches to target the microenvironment of bone metastasis.

Authors:  Lorenz C Hofbauer; Aline Bozec; Martina Rauner; Franz Jakob; Sven Perner; Klaus Pantel
Journal:  Nat Rev Clin Oncol       Date:  2021-04-19       Impact factor: 66.675

2.  Effects of macrophage colony-stimulating factor on macrophages and their related cell populations in the osteopetrosis mouse defective in production of functional macrophage colony-stimulating factor protein.

Authors:  S Umeda; K Takahashi; L D Shultz; M Naito; K Takagi
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  A comparison of the effects of inhibitors of carbonic anhydrase on osteoclastic bone resorption and purified carbonic anhydrase isozyme II.

Authors:  T J Hall; W Higgins; C Tardif; T J Chambers
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

4.  Abnormal differentiation of tissue macrophage populations in 'osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor.

Authors:  M Naito; S Hayashi; H Yoshida; S Nishikawa; L D Shultz; K Takahashi
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

5.  Mineral and matrix alterations in the bones of incisors-absent (ia/ia) osteopetrotic rats.

Authors:  A L Boskey; S C Marks
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

6.  Downregulation of colony-stimulating factor-1 (CSF-1) binding by CSF-1 in isolated osteoclasts.

Authors:  H Amano; W Hofstetter; M G Cecchini; H Fleisch; R Felix
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

7.  Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.

Authors:  W S Sly; D Hewett-Emmett; M P Whyte; Y S Yu; R E Tashian
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  N-ethyl-N-nitrosourea-induced null mutation at the mouse Car-2 locus: an animal model for human carbonic anhydrase II deficiency syndrome.

Authors:  S E Lewis; R P Erickson; L B Barnett; P J Venta; R E Tashian
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Endostatin inhibits VEGF-A induced osteoclastic bone resorption in vitro.

Authors:  Annina Sipola; Katri Nelo; Timo Hautala; Joanna Ilvesaro; Juha Tuukkanen
Journal:  BMC Musculoskelet Disord       Date:  2006-07-13       Impact factor: 2.362

10.  Delayed hematopoietic development in osteopetrotic (op/op) mice.

Authors:  S K Begg; J M Radley; J W Pollard; O T Chisholm; E R Stanley; I Bertoncello
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.